<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/mostaccessed?quantity=&amp;format=rss&amp;version=">
        <title>BioMed Central - Most accessed articles</title>
        <link>http://www.biomedcentral.com/</link>
        <description>The most accessed research articles published by BioMed Central</description>
        <dc:date>2010-02-25T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.ojrd.com/content/3/1/15" />
                                <rdf:li rdf:resource="http://www.nutritionj.com/content/4/1/24" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2288/10/12" />
                                <rdf:li rdf:resource="http://www.retrovirology.com/content/7/1/10" />
                                <rdf:li rdf:resource="http://www.ijbnpa.org/content/1/1/3" />
                                <rdf:li rdf:resource="http://www.chiroandosteo.com/content/18/1/3" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/2/1/3" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/3/1/6" />
                                <rdf:li rdf:resource="http://ccforum.com/content/8/4/R204" />
                                <rdf:li rdf:resource="http://jbiol.com/content/9/2/10" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.ojrd.com/content/3/1/15">
        <title>Brachydactyly</title>
        <description>Brachydactyly (&quot;short digits&quot;) is a general term that refers to disproportionately short fingers and toes, and forms part of the group of limb malformations characterized by bone dysostosis. The various types of isolated brachydactyly are rare, except for types A3 and D. Brachydactyly can occur either as an isolated malformation or as a part of a complex malformation syndrome. To date, many different forms of brachydactyly have been identified. Some forms also result in short stature. In isolated brachydactyly, subtle changes elsewhere may be present. Brachydactyly may also be accompanied by other hand malformations, such as syndactyly, polydactyly, reduction defects, or symphalangism.For the majority of isolated brachydactylies and some syndromic forms of brachydactyly, the causative gene defect has been identified. In isolated brachydactyly, the inheritance is mostly autosomal dominant with variable expressivity and penetrtance.Diagnosis is clinical, anthropometric and radiological. Prenatal diagnosis is usually not indicated for isolated forms of brachydactyly, but may be appropriate in syndromic forms. Molecular studies of chorionic villus samples at 11 weeks of gestation and by amniocentesis after the 14th week of gestation can provide antenatal diagnosis if the causative mutation in the family is known. The nature of genetic counseling depends both on the pattern of inheritance of the type of brachydactyly present in the family and on the presence or absence of accompanying symptoms.There is no specific management or treatment that is applicable to all forms of brachydactyly. Plastic surgery is only indicated if the brachydactyly affects hand function or for cosmetic reasons, but is typically not needed. Physical therapy and ergotherapy may ameliorate hand function. Prognosis for the brachydactylies is strongly dependent on the nature of the brachydactyly, and may vary from excellent to severely influencing hand function. If brachydactyly forms part of a syndromic entity, prognosis often depends on the nature of the associated anomalies.</description>
        <link>http://www.ojrd.com/content/3/1/15</link>
                <dc:creator>Samia Temtamy</dc:creator>
                <dc:creator>Mona Aglan</dc:creator>
                <dc:source>Orphanet Journal of Rare Diseases 2008, 3:15</dc:source>
        <dc:date>2008-06-13T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1750-1172-3-15</dc:identifier>
        <prism:publicationName>Orphanet Journal of Rare Diseases</prism:publicationName>
        <prism:issn>1750-1172</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>15</prism:startingPage>
        <prism:publicationDate>2008-06-13T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.nutritionj.com/content/4/1/24">
        <title>Childhood obesity, prevalence and prevention</title>
        <description>Childhood obesity has reached epidemic levels in developed countries. Twenty five percent of children in the US are overweight and 11% are obese. Overweight and obesity in childhood are known to have significant impact on both physical and psychological health. The mechanism of obesity development is not fully understood and it is believed to be a disorder with multiple causes. Environmental factors, lifestyle preferences, and cultural environment play pivotal roles in the rising prevalence of obesity worldwide. In general, overweight and obesity are assumed to be the results of an increase in caloric and fat intake. On the other hand, there are supporting evidence that excessive sugar intake by soft drink, increased portion size, and steady decline in physical activity have been playing major roles in the rising rates of obesity all around the world. Consequently, both over-consumption of calories and reduced physical activity are involved in childhood obesity.Almost all researchers agree that prevention could be the key strategy for controlling the current epidemic of obesity. Prevention may include primary prevention of overweight or obesity, secondary prevention or prevention of weight regains following weight loss, and avoidance of more weight increase in obese persons unable to lose weight. Until now, most approaches have focused on changing the behaviour of individuals in diet and exercise. It seems, however, that these strategies have had little impact on the growing increase of the obesity epidemic. While about 50% of the adults are overweight and obese in many countries, it is difficult to reduce excessive weight once it becomes established. Children should therefore be considered the priority population for intervention strategies. Prevention may be achieved through a variety of interventions targeting built environment, physical activity, and diet. Some of these potential strategies for intervention in children can be implemented by targeting preschool institutions, schools or after-school care services as natural setting for influencing the diet and physical activity. All in all, there is an urgent need to initiate prevention and treatment of obesity in children.</description>
        <link>http://www.nutritionj.com/content/4/1/24</link>
                <dc:creator>Mahshid Dehghan</dc:creator>
                <dc:creator>Noori Akhtar-Danesh</dc:creator>
                <dc:creator>Anwar Merchant</dc:creator>
                <dc:source>Nutrition Journal 2005, 4:24</dc:source>
        <dc:date>2005-09-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1475-2891-4-24</dc:identifier>
        <prism:publicationName>Nutrition Journal</prism:publicationName>
        <prism:issn>1475-2891</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>24</prism:startingPage>
        <prism:publicationDate>2005-09-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2288/10/12">
        <title>The Manchester Color Wheel: development of a novel way of identifying color choice and its validation in healthy, anxious and depressed individuals</title>
        <description>Background:
For the purposes of our research programme we needed a simple, reliable and validated method for allowing choice of a color in response to a series of questions. On reviewing the literature no such instrument was available and this study aimed to rectify this situation. This was achieved by developing a simple method of presenting a series of colors to people validating it in healthy volunteers and in individuals where color choice might be distorted, namely anxiety and depression.
Methods:
A series of different presentations of four shades of eight colors and grey, as well as black and white were evaluated. &apos;Mood&apos;, &apos;favourite&apos; and &apos;drawn to&apos; colors were assessed in 105 healthy, 108 anxious and 110 depressed participants. The positive, neutral or negative attribution of these colors was recorded in a further 204 healthy volunteers.
Results:
The circular presentation of colors was most favoured (Color Wheel). Yellow was the most &apos;drawn to&apos; color and blue the commonest &apos;favourite&apos; color in all subjects. Yellow was most often associated with a normal mood and grey with an anxious or depressed mood. Different shades of the same color had completely different positive or negative connotations. Reproducibility was exceptionally high when color choice was recorded in positive, neutral or negative terms.
Conclusions:
The Color Wheel could be used to assess health status, mood or even treatment outcome in a variety of clinical situations. It may also have utility in circumstances where verbal communication may not be optimal, such as with children.</description>
        <link>http://www.biomedcentral.com/1471-2288/10/12</link>
                <dc:creator>Helen Carruthers</dc:creator>
                <dc:creator>Julie Morris</dc:creator>
                <dc:creator>Nicholas Tarrier</dc:creator>
                <dc:creator>Peter Whorwell</dc:creator>
                <dc:source>BMC Medical Research Methodology 2010, 10:12</dc:source>
        <dc:date>2010-02-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2288-10-12</dc:identifier>
        <prism:publicationName>BMC Medical Research Methodology</prism:publicationName>
        <prism:issn>1471-2288</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2010-02-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.retrovirology.com/content/7/1/10">
        <title>Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome</title>
        <description>Background:
Detection of a retrovirus, xenotropic murine leukaemia virus-related virus (XMRV), has recently been reported in 67% of patients with chronic fatigue syndrome. We have studied a total of 170 samples from chronic fatigue syndrome patients from two UK cohorts and 395 controls for evidence of XMRV infection by looking either for the presence of viral nucleic acids using quantitative PCR (limit of detection &lt;16 viral copies) or for the presence of serological responses using a virus neutralisation assay.
Results:
We have not identified XMRV DNA in any samples by PCR (0/299).  Some serum samples showed XMRV neutralising activity (26/565) but only one of these positive sera came from a CFS patient.  Most of the positive sera were also able to neutralise MLV particles pseudotyped with envelope proteins from other viruses, including vesicular stomatitis virus, indicating significant cross-reactivity in serological responses. Four positive samples were specific for XMRV.
Conclusions:
No association between XMRV infection and CFS was observed in the samples tested, either by PCR or serological methodologies. The non-specific neutralisation observed in multiple serum samples suggests that it is unlikely that these responses were elicited by XMRV and highlights the danger of over-estimating XMRV frequency based on serological assays. In spite of this, we believe that the detection of neutralising activity that did not inhibit VSV-G pseudotyped MLV in at least four human serum samples indicates that XMRV infection may occur in the general population, although with currently uncertain outcomes.</description>
        <link>http://www.retrovirology.com/content/7/1/10</link>
                <dc:creator>Harriet Groom</dc:creator>
                <dc:creator>Virginie Boucherit</dc:creator>
                <dc:creator>Kerry Makinson</dc:creator>
                <dc:creator>Edward Randal</dc:creator>
                <dc:creator>Sarah Baptista</dc:creator>
                <dc:creator>Suzanne Hagan</dc:creator>
                <dc:creator>John Gow</dc:creator>
                <dc:creator>Frank Mattes</dc:creator>
                <dc:creator>Judith Breuer</dc:creator>
                <dc:creator>Jonathan Kerr</dc:creator>
                <dc:creator>Jonathan Stoye</dc:creator>
                <dc:creator>Kate Bishop</dc:creator>
                <dc:source>Retrovirology 2010, 7:10</dc:source>
        <dc:date>2010-02-15T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1742-4690-7-10</dc:identifier>
        <prism:publicationName>Retrovirology</prism:publicationName>
        <prism:issn>1742-4690</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2010-02-15T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.ijbnpa.org/content/1/1/3">
        <title>Food Advertising and Marketing Directed at Children and Adolescents in the US</title>
        <description>In recent years, the food and beverage industry in the US has viewed children and adolescents as a major market force. As a result, children and adolescents are now the target of intense and specialized food marketing and advertising efforts. Food marketers are interested in youth as consumers because of their spending power, their purchasing influence, and as future adult consumers. Multiple techniques and channels are used to reach youth, beginning when they are toddlers, to foster brand-building and influence food product purchase behavior. These food marketing channels include television advertising, in-school marketing, product placements, kids clubs, the Internet, toys and products with brand logos, and youth-targeted promotions, such as cross-selling and tie-ins. Foods marketed to children are predominantly high in sugar and fat, and as such are inconsistent with national dietary recommendations. The purpose of this article is to examine the food advertising and marketing channels used to target children and adolescents in the US, the impact of food advertising on eating behavior, and current regulation and policies.</description>
        <link>http://www.ijbnpa.org/content/1/1/3</link>
                <dc:creator>Mary Story</dc:creator>
                <dc:creator>Simone French</dc:creator>
                <dc:source>International Journal of Behavioral Nutrition and Physical Activity 2004, 1:3</dc:source>
        <dc:date>2004-02-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1479-5868-1-3</dc:identifier>
        <prism:publicationName>International Journal of Behavioral Nutrition and Physical Activity</prism:publicationName>
        <prism:issn>1479-5868</prism:issn>
        <prism:volume>1</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2004-02-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.chiroandosteo.com/content/18/1/3">
        <title>Effectiveness of manual therapies: the UK evidence report</title>
        <description>Background:
The purpose of this report is to provide a succinct but comprehensive summary of the scientific evidence regarding the effectiveness of manual treatment for the management of a variety of musculoskeletal and non-musculoskeletal conditions.
Methods:
The conclusions are based on the results of systematic reviews of randomized clinical trials (RCTs), widely accepted and primarily UK and United States evidence-based clinical guidelines, plus the results of all RCTs not yet included in the first three categories. The strength/quality of the evidence regarding effectiveness was based on an adapted version of the grading system developed by the US Preventive Services Task Force and a study risk of bias assessment tool for the recent RCTs.
Results:
By September 2009, 26 categories of conditions were located containing RCT evidence for the use of manual therapy: 13 musculoskeletal conditions, four types of chronic headache and nine non-musculoskeletal conditions. We identified 49 recent relevant systematic reviews and 16 evidence-based clinical guidelines plus an additional 46 RCTs not yet included in systematic reviews and guidelines.Additionally, brief references are made to other effective non-pharmacological, non-invasive physical treatments.
Conclusions:
Spinal manipulation/mobilization is effective in adults for: acute, subacute, and chronic low back pain; migraine and cervicogenic headache; cervicogenic dizziness;  manipulation/mobilization is effective for several extremity joint conditions; and  thoracic manipulation/mobilization is effective for acute/subacute neck pain. The evidence is inconclusive for cervical manipulation/mobilization alone for neck pain of any duration, and for manipulation/mobilization for mid back pain, sciatica, tension-type headache, coccydynia, temporomandibular joint disorders, fibromyalgia, premenstrual syndrome, and pneumonia in older adults. Spinal manipulation is not effective for asthma and dysmenorrhea when compared to sham manipulation, or for Stage 1 hypertension when added to an antihypertensive diet. In children, the evidence is inconclusive regarding the effectiveness for otitis media and enuresis, and it is not effective for infantile colic and asthma when compared to sham manipulation.Massage is effective in adults for chronic low back pain and chronic neck pain. The evidence is inconclusive for knee osteoarthritis, fibromyalgia, myofascial pain syndrome, migraine headache, and premenstrual syndrome. In children, the evidence is inconclusive for asthma and infantile colic.</description>
        <link>http://www.chiroandosteo.com/content/18/1/3</link>
                <dc:creator>Gert Bronfort</dc:creator>
                <dc:creator>Mitchell Haas</dc:creator>
                <dc:creator>Roni Evans</dc:creator>
                <dc:creator>Brent Leiniger</dc:creator>
                <dc:creator>John Triano</dc:creator>
                <dc:source>Chiropractic &amp; Osteopathy 2010, 18:3</dc:source>
        <dc:date>2010-02-25T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1746-1340-18-3</dc:identifier>
        <prism:publicationName>Chiropractic &amp; Osteopathy</prism:publicationName>
        <prism:issn>1746-1340</prism:issn>
        <prism:volume>18</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2010-02-25T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/2/1/3">
        <title>Applications of nanoparticles in biology and medicine</title>
        <description>Nanomaterials are at the leading edge of the rapidly developing field of nanotechnology. Their unique size-dependent properties make these materials superior and indispensable in many areas of human activity. This brief review tries to summarise the most recent developments in the field of applied nanomaterials, in particular their application in biology and medicine, and discusses their commercialisation prospects.</description>
        <link>http://www.jnanobiotechnology.com/content/2/1/3</link>
                <dc:creator>O Salata</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2004, 2:3</dc:source>
        <dc:date>2004-04-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-2-3</dc:identifier>
        <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>2</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2004-04-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/3/1/6">
        <title>Interaction of silver nanoparticles with HIV-1</title>
        <description>The interaction of nanoparticles with biomolecules and microorganisms is an expanding field of research. Within this field, an area that has been largely unexplored is the interaction of metal nanoparticles with viruses. In this work, we demonstrate that silver nanoparticles undergo a size-dependent interaction with HIV-1, with nanoparticles exclusively in the range of 1&#8211;10 nm attached to the virus. The regular spatial arrangement of the attached nanoparticles, the center-to-center distance between nanoparticles, and the fact that the exposed sulfur-bearing residues of the glycoprotein knobs would be attractive sites for nanoparticle interaction suggest that silver nanoparticles interact with the HIV-1 virus via preferential binding to the gp120 glycoprotein knobs. Due to this interaction, silver nanoparticles inhibit the virus from binding to host cells, as demonstrated in vitro.</description>
        <link>http://www.jnanobiotechnology.com/content/3/1/6</link>
                <dc:creator>Jose Luis Elechiguerra</dc:creator>
                <dc:creator>Justin Burt</dc:creator>
                <dc:creator>Jose Morones</dc:creator>
                <dc:creator>Alejandra Camacho-Bragado</dc:creator>
                <dc:creator>Xiaoxia Gao</dc:creator>
                <dc:creator>Humberto Lara</dc:creator>
                <dc:creator>Miguel Jose Yacaman</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2005, 3:6</dc:source>
        <dc:date>2005-06-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-3-6</dc:identifier>
        <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2005-06-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://ccforum.com/content/8/4/R204">
        <title>Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group</title>
        <description>IntroductionThere is no consensus definition of acute renal failure (ARF) in critically ill patients. More than 30 different definitions have been used in the literature, creating much confusion and making comparisons difficult. Similarly, strong debate exists on the validity and clinical relevance of animal models of ARF; on choices of fluid management and of end-points for trials of new interventions in this field; and on how information technology can be used to assist this process. Accordingly, we sought to review the available evidence, make recommendations and delineate key questions for future studies.
Methods:
We undertook a systematic review of the literature using Medline and PubMed searches. We determined a list of key questions and convened a 2-day consensus conference to develop summary statements via a series of alternating breakout and plenary sessions. In these sessions, we identified supporting evidence and generated recommendations and/or directions for future research.
Results:
We found sufficient consensus on 47 questions to allow the development of recommendations. Importantly, we were able to develop a consensus definition for ARF. In some cases it was also possible to issue useful consensus recommendations for future investigations. We present a summary of the findings. (Full versions of the six workgroups&apos; findings are available on the internet at http://www.ADQI.net)
Conclusion:
Despite limited data, broad areas of consensus exist for the physiological and clinical principles needed to guide the development of consensus recommendations for defining ARF, selection of animal models, methods of monitoring fluid therapy, choice of physiological and clinical end-points for trials, and the possible role of information technology.</description>
        <link>http://ccforum.com/content/8/4/R204</link>
                <dc:creator>Rinaldo Bellomo</dc:creator>
                <dc:creator>Claudio Ronco</dc:creator>
                <dc:creator>John Kellum</dc:creator>
                <dc:creator>Ravindra Mehta</dc:creator>
                <dc:creator>Paul Palevski</dc:creator>
                <dc:source>Critical Care 2004, 8:R204</dc:source>
        <dc:date>2004-05-24T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/cc2872</dc:identifier>
        <prism:publicationName>Critical Care</prism:publicationName>
        <prism:issn>1364-8535</prism:issn>
        <prism:volume>8</prism:volume>
        <prism:startingPage>R204</prism:startingPage>
        <prism:publicationDate>2004-05-24T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://jbiol.com/content/9/2/10">
        <title>Top dogs: wolf domestication and wealth</title>
        <description>A phylogeographic analysis of gene sequences important in determining body size in dogs, recently published in BMC Biology, traces the appearance of small body size to the Neolithic Middle East. This finding strengthens the association of this event with the development of sedentary societies, and perhaps even has implications for the inception of human social inequality.See research article http://www.biomedcentral.com/1741-7007/8/16/</description>
        <link>http://jbiol.com/content/9/2/10</link>
                <dc:source>Journal of Biology 2010, 9:10</dc:source>
        <dc:date>2010-02-24T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/jbiol226</dc:identifier>
        <prism:publicationName>Journal of Biology</prism:publicationName>
        <prism:issn>1475-4924</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2010-02-24T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
